Hai Chuang Pharmaceutical Industry: By 2025, the operating revenue is 20.6738 million yuan, an increase of 20.307 million yuan compared to the same period last year.

Hai Chuang Pharmaceutical announced that in 2025, it achieved operating income of 2067.38 million yuan, an increase of 2030.7 million yuan compared to the previous year; the net profit attributable to the owner of the parent company was -137 million yuan, a decrease of 6280.83 million yuan compared to the previous year; the net profit after deducting non-recurring gains and losses attributable to the owner of the parent company was -167 million yuan, a decrease of 5014.17 million yuan compared to the previous year.